04.06.2015 Views

2012 Scientific Report - Queensland Children's Medical Research ...

2012 Scientific Report - Queensland Children's Medical Research ...

2012 Scientific Report - Queensland Children's Medical Research ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

‣ The Clinical Trials Unit in the QPID laboratory has continued to conduct a number of<br />

externally-funded clinical and new drug trials. The primary interest of the CTU is<br />

infectious diseases, particularly vaccine preventable diseases. Often this involves early<br />

phase trials in children and older age groups, to identify improved, safer, and more<br />

effective prevention and treatment options. The unit has developed an international<br />

reputation and continues be recognised for its significant contribution made in this<br />

area of the Children’s Health <strong>Queensland</strong> Hospitals and Health Service activities.<br />

<strong>Research</strong> Grants and Contracts<br />

Years<br />

<strong>2012</strong>-<br />

2014<br />

Grant Chief Investigators Title Amount<br />

Agency<br />

QCMRI Seweryn Bialasiewicz QCMRI Early Career Fellowship $450,000<br />

<strong>2012</strong> QCMRI Seweryn Bialasiewicz NHMRC Near-Miss Funding $50,000<br />

2010-<br />

<strong>2012</strong><br />

ARC<br />

Ian Mackay, Theo P<br />

Sloots<br />

Seeking causes of unexplained<br />

respiratory illness in children by<br />

identifying new respiratory<br />

viruses<br />

$245,000<br />

2010-<br />

<strong>2012</strong><br />

QCMRI Ian Mackay Identification and clinical impact<br />

of non-rhinovirus picornaviruses<br />

in respiratory disease<br />

$300,000<br />

<strong>2012</strong>-<br />

2015<br />

NHMRC<br />

Chang, Morris,<br />

O’Grady, Grimwood,<br />

Sloots, Van Asperen,<br />

Wilson, Robertson<br />

Multicentre randomised<br />

controlled trial to improve the<br />

management of exacerbations<br />

in children with bronchiectasis<br />

$1,148,522<br />

($155,000<br />

QPID)<br />

<strong>2012</strong>-<br />

2015<br />

NHMRC<br />

1019834<br />

Chang, Morris,<br />

Robertson, Grimwood,<br />

Van Asperen, Sloots,<br />

Torzillo, O’Grady,<br />

Wilson<br />

BREATH: Bronchiectasis<br />

Randomised controlled trial-<br />

Evaluation of Azithromycin and<br />

inhaled hypertonic saline for<br />

lung Health maintenance<br />

$2,686,000<br />

(85,000 QPID)<br />

2010-<br />

2015<br />

QCMRI<br />

Sloots T, Nissen MD,<br />

Lambert S, Grimwood<br />

K.<br />

Molecular Microbiology and<br />

Epidemiology of Respiratory<br />

Infections in Children<br />

$2,250,000<br />

2010-<br />

<strong>2012</strong><br />

NHMRC Chang A, Morris P,<br />

Grimwood K, Sloots T,<br />

White A, MacLennan<br />

C.<br />

Randomised controlled trial of<br />

azithromycin to reduce the<br />

morbidity of severe<br />

bronchiolitis in Indigenous<br />

infants.<br />

$1,407,075<br />

2011-<br />

<strong>2012</strong><br />

The Prince<br />

Charles<br />

Bell S, Morawski L,<br />

Wainwright C,<br />

Quantification of infectious<br />

aerosol transport in the air for<br />

$99,828<br />

QCMRI <strong>Scientific</strong> <strong>Report</strong> <strong>2012</strong> 55

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!